Revance Therapeutics | RVNC - Kreditur Perdagangan



Kreditur Perdagangan Perubahan Tanggal
AbbVie USD 3.59B 28.65B 2025-12
ALKERMES USD 142.86M 40.5M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Cara Therapeutics USD 4.62M 1.4M 2026-03
Coherus Biosciences USD 13.17M 1.69M 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
J&J USD 9.22B 1.24B 2026-06
Merck USD 3.83B 36M 2026-06
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
P&G USD 16.31B 1.28B 2026-06
Pacira USD 17.51M 3.5M 2026-06
Supernus Pharmaceuticals USD 5.59M 4.58M 2026-06